Brown VT[au] - Search Results

Year	Number of Results
1978	1
2011	1
2013	1
2014	2
2015	2
2016	1
2017	2
2019	1
2020	3
2021	3
2022	0

1

Appraisal, wellbeing, and pandemics: is a focus on wellbeing now warranted?

McCartney M, Brown VT. McCartney M, et al. Among authors: brown vt. Br J Gen Pract. 2020 Oct 1;70(699):481-482. doi: 10.3399/bjgp20X712697. Print 2020 Oct. Br J Gen Pract. 2020. PMID: 33004358 Free PMC article. No abstract available.

2

I don't want to be a call centre GP!

Gregory S, Brown VT. Gregory S, et al. Among authors: brown vt. Br J Gen Pract. 2020 Jul 30;70(697):405. doi: 10.3399/bjgp20X712049. Print 2020 Aug. Br J Gen Pract. 2020. PMID: 32732211 Free PMC article. No abstract available.

3

The power of personal care: the value of the patient-GP consultation.

Brown VT, Gregory S, Gray DP. Brown VT, et al. Br J Gen Pract. 2020 Nov 26;70(701):596-597. doi: 10.3399/bjgp20X713717. Print 2020 Dec. Br J Gen Pract. 2020. PMID: 33243906 Free PMC article. No abstract available.

4

Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis.

Brown VT, Antol DD, Racsa PN, Ward MA, Naidoo J. Brown VT, et al. Cancer Invest. 2021 Nov;39(10):789-796. doi: 10.1080/07357907.2021.1913502. Epub 2021 Sep 27. Cancer Invest. 2021. PMID: 33829943

5

Multiple myeloma maintenance therapy: a review of the pharmacologic treatment.

Shank BR, Brown VT, Schwartz RN. Shank BR, et al. Among authors: brown vt. J Oncol Pharm Pract. 2015 Feb;21(1):36-51. doi: 10.1177/1078155213514468. Epub 2014 Jan 6. J Oncol Pharm Pract. 2015. PMID: 24395544 Review.

6

A compelling story for change.

Mowle S, Graham M, Huddart M, Brown VT, Burch T. Mowle S, et al. Among authors: brown vt. London J Prim Care (Abingdon). 2014;6(6):109-10. doi: 10.1080/17571472.2014.11494360. London J Prim Care (Abingdon). 2014. PMID: 25949730 Free PMC article. No abstract available.

7

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans.

Caplan EO, Wong WB, Ferries E, Hulinsky R, Brown VT, Bordenave K, Suehs BT. Caplan EO, et al. Among authors: brown vt. JCO Precis Oncol. 2021 May 5;5:PO.20.00422. doi: 10.1200/PO.20.00422. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036226 Free PMC article.

8

Analysis of FDA approvals of targeted anticancer combination regimens.

Brown VT, Cho V, Parkey S. Brown VT, et al. Am J Health Syst Pharm. 2017 Dec 1;74(23):1938-1942. doi: 10.2146/ajhp170029. Am J Health Syst Pharm. 2017. PMID: 29167134 No abstract available.

9

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.

Doshi JA, Jahnke J, Raman S, Puckett JT, Brown VT, Ward MA, Li P, Manz CR. Doshi JA, et al. Among authors: brown vt. J Manag Care Spec Pharm. 2021 Oct;27(10):1457-1468. doi: 10.18553/jmcp.2021.27.10.1457. J Manag Care Spec Pharm. 2021. PMID: 34595957

10

Evaluation of the head and neck cancer patient population and the incidence of hospitalization at an academic medical center.

Hazelden LA, Newman MJ, Shuey S, Waldfogel JM, Brown VT. Hazelden LA, et al. Among authors: brown vt. J Oncol Pharm Pract. 2019 Mar;25(2):333-338. doi: 10.1177/1078155217735688. Epub 2017 Oct 19. J Oncol Pharm Pract. 2019. PMID: 29050538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results